Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Recruiting"
topic_facet:"Phase: Phase 1, Phase 2"
topic_facet:"Colorectal Neoplasms"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&filter%5B%5D=topic_facet%3A%22Colorectal+Neoplasms%22&lookfor=%22610%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&filter%5B%5D=topic_facet%3A%22Colorectal+Neoplasms%22&lookfor=%22610%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%2C+Phase+2%22&filter%5B%5D=topic_facet%3A%22Colorectal+Neoplasms%22&lookfor=%22610%22&type=Subject
PubPharm (81)
1
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness : A Phase 1/2 Trial Evaluating the Combination of Temozolomide and the Ataxia Telangiectasia and Rad3-Related Inhibitor M1774
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, Tolerability and Antitumor Activity of Selinexor Combination Treatment : Open-Label, Phase 1/2 Study Evaluating the Relative Bioavailability/Bioequivalence of Different Formulations of Selinexor, the Impact of Hepatic Impairment on Selinexor Pharmacokinetics, and the Tolerability and Antitumor Activity of Selinexor Combination Treatment (SPRINT)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors : A Phase 1/2 Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) : A Phase 1/2 Study of LY3537982 in Patients With KRAS G12C-Mutant Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas : A Phase 1/2a, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors : First in Human Phase 1/2 Trial of ELI-002 7P Immunotherapy as Treatment for Subjects With Kirsten Rat Sarcoma (KRAS)/Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers : A Phase 1b/2 Dose Escalation and Expansion Study of Tucatinib in Combination With Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer : A Phase 1b/2 Study of AVUTOMETINIB and Cetuximab in Participants With Advanced KRAS Mutated Colorectal Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation : A Phase Ib/II Open-label, Multi-center Dose Escalation Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors : Phase I/II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Pretreated Patients With Selected Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
Nächster »
[9]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Recruitment Status: Recruiting
Filter aufheben
Thema: Phase: Phase 1, Phase 2
Filter aufheben
Thema: Colorectal Neoplasms
Medienart
81
Aufsätze
81
E-Artikel
81
E-Ressourcen
Zeitschriftentitel
81
ClinicalTrials.gov
Thema
81
610
Colorectal Neoplasms
Phase: Phase 1, Phase 2
Recruitment Status: Recruiting
81
Study Type: Interventional
21
Neoplasms
19
Carcinoma
15
Carcinoma, Non-Small-Cell Lung
12
Lung Neoplasms
11
Adenocarcinoma
11
Pancreatic Neoplasms
8
Stomach Neoplasms
6
Neoplasm Metastasis
6
Ovarian Neoplasms
5
Breast Neoplasms
5
Carcinoma, Squamous Cell
5
Mesothelioma
5
Squamous Cell Carcinoma of Head and Neck
4
Carcinoma, Transitional Cell
4
Endometrial Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
54
2024
19
2023
4
2022
4
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
81
Englisch
Haven't found what you're looking for?
Wird geladen...